InvestorsHub Logo
Followers 3
Posts 57
Boards Moderated 0
Alias Born 05/20/2014

Re: tatehntr post# 23280

Wednesday, 12/30/2015 12:04:07 PM

Wednesday, December 30, 2015 12:04:07 PM

Post# of 113625
Here's the other side: We anticipate that Phase I clinical trials will commence in late 2016 or early 2017 and we estimate that it will take 18 months to complete. Following successful completion of Phase I clinical trials, we expect to receive limited marketing approval for “compassionate-use” under the FDA and similar guidelines in Canada.- These trials are through McGill University’s Jewish General Hospital

Based on the timeline to receive the samples, they are having the drug made for trials.

The more I look into this, it doesn't look like a shell. It looks like a legitimate company. The question is can they produce what they say they can?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News